{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:14:16Z","timestamp":1767665656567},"reference-count":40,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1993,1,1]]},"DOI":"10.1136\/jnnp.56.1.17","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T22:20:59Z","timestamp":1226355659000},"page":"17-25","source":"Crossref","is-referenced-by-count":141,"title":["Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials."],"prefix":"10.1136","volume":"56","author":[{"given":"P A","family":"Sandercock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A G","family":"van den Belt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R I","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"17","article-title":"Sscanning or venography), pulmonary (J","volume":"56","year":"1993","unstructured":"Sscanning or venography), pulmonary (J Neurol Neurosurg Psychiatry 1993;56:17-25)","journal-title":"Neurol Neurosurg Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.20.5.577","article-title":"Incidence rates of stroke in the eighties: the end of the decline in stroke?","volume":"20","author":"Broderick, J.P.; Phillips, S.J.; Whisnant, J.P.; O'Fallon, W.M.; Bergstralh, E.J.","year":"1989","unstructured":"Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke 1989;20:577-82.","journal-title":"Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ana.410220209","article-title":"Trends in the incidence rates of stroke in Rochester, Minnesota, since 1935","volume":"22","author":"Homer, D.; Whisnant, J.P.; Schoenberg, B.S.","year":"1987","unstructured":"Homer D, Whisnant JP, Schoenberg BS. Trends in the incidence rates of stroke in Rochester, Minnesota, since 1935. Ann Neurol 1987;22:245-51.","journal-title":"Ann Neurol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"The RISC group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","year":"1990","unstructured":"The RISC group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990;336:827-30.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"or both to treat acute unstable angina","volume":"319","author":"Theroux, P.; Ouimet, H.; McCans, J.","year":"1988","unstructured":"Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl Med 1988;319:1105-11.","journal-title":"N Engl Med"},{"key":"ref_6","first-page":"231","article-title":"Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery","volume":"18","author":"Cairns, J.A.","year":"1987","unstructured":"Cairns JA. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery. Cardiovasc Clin 1987;18: 231-46.","journal-title":"Cardiovasc Clin"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"et aL Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis, H.D.; Davis, J.W.; Archibald, D.G.","year":"1983","unstructured":"Lewis HD, Davis JW, Archibald DG, et aL Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl Med 1983;309: 396-403.","journal-title":"N Engl Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM198902093200604","article-title":"Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction","volume":"320","author":"Turpie, A.G.G.; Robinson, J.G.; Doyle, D.J.","year":"1989","unstructured":"Turpie AGG, Robinson JG, Doyle DJ, et al. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl Med 1989;320:352-7.","journal-title":"N Engl Med"},{"key":"ref_9","first-page":"182","article-title":"The SCATI (Studio sulla calciparina nell'angina e nella trombosi venticolare nell'infarto) group. Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction","volume":"2","year":"1989","unstructured":"The SCATI (Studio sulla calciparina nell'angina e nella trombosi venticolare nell'infarto) group. Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction. Lancetr 1989;2: 182-6.","journal-title":"Lancetr"},{"issue":"65-7","key":"ref_10","first-page":"1","article-title":"Gruppo Italiano per lo studio della sopravvivenza nell'infarto miocardico. GISSI- 2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction","volume":"336","year":"1990","unstructured":"Gruppo Italiano per lo studio della sopravvivenza nell'infarto miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-7 1.","journal-title":"Lancet"},{"key":"ref_11","first-page":"225","article-title":"Acetylsalicylic acid for the prevention of venous thromboembolic disease in surgical patients","volume-title":"acid: new uses for an old drug","author":"Salzman, E.W.; Harris, W.H.","year":"1982","unstructured":"Salzman EW, Harris WH. Acetylsalicylic acid for the prevention of venous thromboembolic disease in surgical patients. In: Bamett HJM, Hirsh J, eds. Acetylsalicylic acid: new uses for an old drug. New York: Raven Press, 1982:225-34."},{"issue":"1","key":"ref_12","first-page":"162","article-title":"Reduction in fatalpulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin","volume":"318","author":"Collins, R.; ScrimgeourA, Yusuf; S, Peto; R.","year":"1988","unstructured":"Collins R, ScrimgeourA,Yusuf S, Peto R. Reduction in fatalpulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl Med 1988;318:1 162-73.","journal-title":"N Engl Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","article-title":"Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction","volume":"260","author":"Yusuf, S.; Wittes, J.; Friedman, L.","year":"1988","unstructured":"Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988;260: 2088-93.","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/sim.4780030421","article-title":"Why do we need some large, simple randomised trials?","volume":"3","author":"Yusuf, S.; Collins, R.; Peto, R.","year":"1984","unstructured":"Yusuf S, Collins R, Peto R. Why do we need some large, simple randomised trials? Stat Med 1984;3:409-20.","journal-title":"Stat Med"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomised trials","volume":"27","author":"YusufS, Peto R.; J, Lewis; R, Collins; P, Sleight","year":"1985","unstructured":"YusufS, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985;27:335-7 1.","journal-title":"Prog Cardiovasc Dis"},{"key":"ref_16","first-page":"320","article-title":"Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists'","volume":"296","year":"1988","unstructured":"Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration. BMJ 1988;296: 320-31.","journal-title":"Collaboration. BMJ"},{"key":"ref_17","article-title":"Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer, vol I: worldwide evidence 1985-1990","year":"1990","unstructured":"Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer, vol I: worldwide evidence 1985-1990. Oxford: Oxford University Press, 1990."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-105-6-825","article-title":"Intravenous heparin for the prevention of stroke progression in acute partial stable stroke","volume":"105","author":"Duke, R.J.; Bloch, R.F.; Turpie, A.G.G.; Trebilcock, R.; Bayer, N.","year":"1986","unstructured":"Duke RJ, Bloch RF, Turpie AGG, Trebilcock R, Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med 1986;105:825-8.","journal-title":"Ann Intern Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.STR.14.5.668","article-title":"Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomised trial","volume":"14","year":"1983","unstructured":"Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomised trial. Stroke 1983;14:668-76.","journal-title":"Stroke"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ageing\/15.2.84","article-title":"Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke","volume":"15","author":"McCarthy, S.T.; Turner, J.","year":"1986","unstructured":"McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing 1986;15:84-8.","journal-title":"Age Ageing"},{"key":"ref_21","first-page":"800","article-title":"Low dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke","volume":"2","author":"McCarthy, S.T.; Robertson, D.; Turner, J.J.; Hawkey, C.J.","year":"1977","unstructured":"McCarthy ST, Robertson D, Turner JJ, Hawkey CJ. Low dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 1977;2:800-1.","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1055\/s-2008-1070492","article-title":"Prophylaxe venoser thrombosen bei frischem ischamischem zerebrovaskularem insultdoppel-blindstudie mit heparin-dihydergot","volume":"106","author":"Czechanowski, B.; Heinrich, F.","year":"1981","unstructured":"Czechanowski B, Heinrich F. Prophylaxe venoser thrombosen bei frischem ischamischem zerebrovaskularem insultdoppel-blindstudie mit heparin-dihydergot. Dtsch Med Wochenschr 1981;106: 1254-60.","journal-title":"Dtsch Med Wochenschr"},{"key":"ref_23","first-page":"399","article-title":"Clinical trial of low-dose subcutaneous heparin for the prevention of stroke progression: natural history of acute partial stroke and stroke-in-evolution","author":"Duke, R.J.; Turpie, A.G.; Bloch, R.F.; Trebilcock, R.G.","year":"1983","unstructured":"Duke RJ, Turpie AG, Bloch RF, Trebilcock RG. Clinical trial of low-dose subcutaneous heparin for the prevention of stroke progression: natural history of acute partial stroke and stroke-in-evolution. In: Reivich M, Hurtig HI, eds. Cerebrovascular disease. New York:Raven Press, 1983:399-405."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(87)90173-5","article-title":"Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke","volume":"1","author":"Turpie, A.G.; Levine, M.N.; Hirsh, J.","year":"1987","unstructured":"Turpie AG, Levine MN, Hirsh J, et al. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet 1987;1:523-6.","journal-title":"Lancet"},{"key":"ref_25","first-page":"245","article-title":"Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165\/Fragmin) in stroke patients","volume":"19","author":"Prins, M.H.; Gelsema, R.; Sing, A.K.; van Heerde, L.R.; den Ottolander, G.J.H.","year":"1989","unstructured":"Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJH. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165\/Fragmin) in stroke patients. Haemostasis 1989;19:245-50.","journal-title":"Haemostasis"},{"key":"ref_26","first-page":"25","article-title":"A double-blind and randomised placebocontrolled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischaemic stroke. Seminars in thrombosis and hemostasis 1990;(suppl 16)","author":"Sandset, P.M.; Dahl, T.; Stiris, M.; Rostad, B.; Scheel, B.; Abildgaard, U.","unstructured":"Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U. A double-blind and randomised placebocontrolled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischaemic stroke. Seminars in thrombosis and hemostasis 1990;(suppl 16):25-33."},{"key":"ref_27","first-page":"95","article-title":"et aL Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study","volume":"11","author":"Elias, A.; Milandre, L.; Lagrange, G.","year":"1990","unstructured":"Elias A, Milandre L, Lagrange G, et aL Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients). Rev Med Interne 1990; 11:95-8.","journal-title":"Rev Med Interne"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(60)90885-0","article-title":"Anticoagulant therapy in acute cerebrovascular accidents: a controlled trial","author":"Marshall, J.; Shaw, D.A.","year":"1960","unstructured":"Marshall J, Shaw DA. Anticoagulant therapy in acute cerebrovascular accidents: a controlled trial. Lancet 1960;995-8.","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/BF01727666","article-title":"Heparin therapy, deep vein thrombosis and pulmonary embolism after intracerebral haemorrhage","volume":"66","author":"Dickmann, U.; Voth, E.; Schicha, H.; Henze, T.; Prange, H.; Emrich, D.","year":"1988","unstructured":"Dickmann U, Voth E, Schicha H, Henze T, Prange H, Emrich D. Heparin therapy, deep vein thrombosis and pulmonary embolism after intracerebral haemorrhage. Klin Wochenschr 1988;66:1182-3.","journal-title":"Klin Wochenschr"},{"key":"ref_30","article-title":"Evaluation of the utility of ticlopidine, an antiplatelet agent, for acute cerebral infarction (Sanofi technical report)","author":"Utsumi, H.","year":"1990","unstructured":"Utsumi H. Evaluation of the utility of ticlopidine, an antiplatelet agent, for acute cerebral infarction (Sanofi technical report). Manchester: Sanofi, 1990."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.STR.20.5.609","article-title":"Effect of therapy on platelet activating factor-induced aggregation in acute stroke","volume":"20","author":"Joseph, R.; Welch, K.M.; D'Andrea, G.","year":"1989","unstructured":"Joseph R, Welch KM, D'Andrea G. Effect of therapy on platelet activating factor-induced aggregation in acute stroke. Stroke 1989;20:609-611.","journal-title":"Stroke"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/000331979004100701","article-title":"Effects of ticlopidine on the neurologic outcome and the hemorheologic pattem in the postacute phase of ischaemic stroke: a pilot study","volume":"41","author":"Ciuffetti, G.; Aisa, G.; Mercuri, M.; Lombardini, R.; Paltriccia, R.; Neri, C.; Senin, U.","year":"1990","unstructured":"Ciuffetti G, Aisa G, Mercuri M, Lombardini R, Paltriccia R, Neri C, Senin U. Effects of ticlopidine on the neurologic outcome and the hemorheologic pattem in the postacute phase of ischaemic stroke: a pilot study. Angiology 1990;41:505-1 1.","journal-title":"Angiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.39.12.1631","article-title":"Use of antithrombotic drugs in the treatment of acute ischaemic stroke. A survey of neurologists in practice in the United States","volume":"39","author":"Marsh, E.E.; Adams, H.P.; Biller, J.; Wasek, P.; Banwart, K.; MitchellV, Woolson; R.","year":"1989","unstructured":"Marsh EE, Adams HP, Biller J, Wasek P, Banwart K, MitchellV,Woolson R. Use of antithrombotic drugs in the treatment of acute ischaemic stroke. A survey of neurologists in practice in the United States. Neurology 1989;39: 1631-4.","journal-title":"Neurology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.STR.19.5.547","article-title":"The stroke data bank; design, methods and baseline characteristics","volume":"19","author":"Foulkes, M.A.; Wolf, P.A.; Price, T.R.","year":"1988","unstructured":"Foulkes MA, Wolf PA, Price TR. The stroke data bank; design, methods and baseline characteristics. Stroke 1988;19:547-54.","journal-title":"Stroke"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.STR.22.2.155","article-title":"Stroke recurrence within 2 years after ischaemic infarction","volume":"22","author":"Hier, D.B.; Foulkes, M.A.; Swiontoniowski, M.","year":"1991","unstructured":"Hier DB, Foulkes MA, Swiontoniowski M, et al. Stroke recurrence within 2 years after ischaemic infarction. Stroke 1991;22:155-61.","journal-title":"Stroke"},{"key":"ref_36","first-page":"98","article-title":"Reduction in major morbidity and mortality by heparin in acute myocardial infarction","volume":"78","author":"MacMahon, S.; Collins, R.; Knight, C.","year":"1988","unstructured":"MacMahon S, Collins R, Knight C. Reduction in major morbidity and mortality by heparin in acute myocardial infarction. Circulation 1988;78:II-98.","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.STR.17.1.111","article-title":"Haemorrhagic complications of longterm anticoagulant therapy for ischaemic cerebral vascular disease","volume":"17","author":"Levine, M.N.; Hirsh, J.","year":"1986","unstructured":"Levine MN, Hirsh J. Haemorrhagic complications of longterm anticoagulant therapy for ischaemic cerebral vascular disease. Stroke 1986;17:111-16.","journal-title":"Stroke"},{"key":"ref_38","first-page":"347","article-title":"An overview of clinical trials of low molecular weight heparin fractions","volume":"30","author":"Levine, M.","year":"1989","unstructured":"Levine M. An overview of clinical trials of low molecular weight heparin fractions. Agressologie 1989;30:347-8.","journal-title":"Agressologie"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.STR.19.8.1043","article-title":"Anticoagulant therapy in cerebrovascular disease: review and meta-analysis","volume":"19","author":"Jonas, S.","year":"1988","unstructured":"Jonas S. Anticoagulant therapy in cerebrovascular disease: review and meta-analysis. Stroke 1988;19: 1043-8.","journal-title":"Stroke"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.STR.18.3.670","article-title":"Italian Acute Stroke Study Group. The Italian hemodilution trial in acute stroke. Italian Acute Stroke Study Group","volume":"18","year":"1987","unstructured":"Italian Acute Stroke Study Group. The Italian hemodilution trial in acute stroke. Italian Acute Stroke Study Group. Stroke 1987;18:670-6.","journal-title":"Stroke"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.56.1.17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:42:10Z","timestamp":1601088130000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.56.1.17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.56.1.17","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1993,1,1]]}}}